Literature DB >> 25603285

Enriched Intestinal Stem Cell Seeding Improves the Architecture of Tissue-Engineered Intestine.

Yanchun Liu1, Terrence Rager1, Jed Johnson2, Josh Enmark2, Gail E Besner1.   

Abstract

OBJECTIVE: To develop a methodology to separate intestinal stem cell (ISC)-enriched crypts from differentiated epithelial cell (DEC)-containing villi to improve the morphology of tissue-engineered intestine (TEI).
METHODS: Small intestinal tissues from 5- to 7-day-old transgenic Lgr5-EGFP mice (with fluorescently labeled ISCs) were used to measure the height of villi and the depth of crypts. Based on the significant size difference between crypts and villi, a novel cell filtration system was developed. Filtration of mixed organoid units from full-thickness intestine of transgenic Lgr5-EGFP mice allowed determination of the percentage of ISCs in the different size-based filtration fractions obtained. In vivo, 5-7-day-old Lewis rat pups were used as cell donors to obtain purified crypts and villi, and the dams of the pups served as recipients. Flat and tubular polyglycolic acid (PGA) scaffolds were seeded with either ISC-enriched crypts or DEC-containing villi and implanted intra-abdominally on the anterior abdominal wall. After 1, 3, 7, 14, 21, and 28 days of in vivo incubation, explants were processed for histologic evaluation.
RESULTS: Small intestine from transgenic Lgr5-EGFP mice contained villi with an average height of 134.89±41.91 μm and crypts with an average depth of 49.59±8.95 μm. After filtration, we found that the 100-200 μm fractions contained relatively pure villi in which DECs were located, whereas the 25-70 μm range fractions contained concentrated crypts in which ISCs were located. In vivo, flat PGA scaffolds implanted with purified crypts formed well-developed mucosa by day 14 postimplantation, whereas flat scaffolds seeded with villi were replaced with fibrous tissue. Tubular scaffolds seeded with the crypt fraction developed a well-formed mucosal layer on the interior surface, with 80.9% circumferential mucosal engraftment and an average villous height of 478±65 μm, which was very close to native intestine (512±98 μm), whereas tubular scaffolds seeded with the villous fraction only had 21.7% circumferential mucosal engraftment and an average villous height of 243±78 μm.
CONCLUSION: The novel filtration system described can effectively and efficiently isolate ISC-containing crypts. TEI produced from ISC-containing crypts has an improved morphology that is similar to native intestine.

Entities:  

Mesh:

Year:  2015        PMID: 25603285     DOI: 10.1089/ten.TEC.2014.0389

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  8 in total

1.  Critical intestinal cells originate from the host in enteroid-derived tissue-engineered intestine.

Authors:  Barrett P Cromeens; Yijie Wang; Yanchun Liu; Jed Johnson; Gail E Besner
Journal:  J Surg Res       Date:  2017-11-28       Impact factor: 2.192

Review 2.  Generation of an artificial intestine for the management of short bowel syndrome.

Authors:  Mitchell R Ladd; Diego F Niño; John C March; Chhinder P Sodhi; David J Hackam
Journal:  Curr Opin Organ Transplant       Date:  2016-04       Impact factor: 2.640

3.  Comparison of polyglycolic acid, polycaprolactone, and collagen as scaffolds for the production of tissue engineered intestine.

Authors:  Yanchun Liu; Tyler Nelson; Jason Chakroff; Barrett Cromeens; Jed Johnson; John Lannutti; Gail E Besner
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2018-09-30       Impact factor: 3.368

4.  Production of Tissue-Engineered Small Intestine in Rats with Different Ages of Cell Donors.

Authors:  Yanchun Liu; Yijie Wang; Jason Chakroff; Jed Johnson; Aidan Farrell; Gail E Besner
Journal:  Tissue Eng Part A       Date:  2018-11-07       Impact factor: 3.845

5.  Comparison of Different In Vivo Incubation Sites to Produce Tissue-Engineered Small Intestine.

Authors:  Yanchun Liu; Barrett P Cromeens; Yijie Wang; Kelli Fisher; Jed Johnson; Jason Chakroff; Gail E Besner
Journal:  Tissue Eng Part A       Date:  2018-03-01       Impact factor: 3.845

Review 6.  Tissue engineering for the treatment of short bowel syndrome in children.

Authors:  Laura Y Martin; Mitchell R Ladd; Adam Werts; Chhinder P Sodhi; John C March; David J Hackam
Journal:  Pediatr Res       Date:  2017-11-01       Impact factor: 3.756

7.  Production of tissue-engineered intestine from expanded enteroids.

Authors:  Barrett P Cromeens; Yanchun Liu; Johnathan Stathopoulos; Yijie Wang; Jed Johnson; Gail E Besner
Journal:  J Surg Res       Date:  2016-03-03       Impact factor: 2.192

Review 8.  Drug Discovery via Human-Derived Stem Cell Organoids.

Authors:  Fangkun Liu; Jing Huang; Bo Ning; Zhixiong Liu; Shen Chen; Wei Zhao
Journal:  Front Pharmacol       Date:  2016-09-22       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.